The digital therapeutics (DTx) market in the US is projected to grow at a compound annual growth rate (CAGR) of 25% from 2022 to 2030, according to a new report.
GlobalData’s DTx in Medical report notes that the growing sector has the potential to improve the care received by patients, offering real-time remote monitoring, “allowing healthcare professionals to track their progress and treatment plans, as well as identify potential issues in real time.”
